ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 50 filers reported holding ALLENA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $13,000 | -59.4% | 9,019 | +9.7% | 0.00% | – |
| Q3 2019 | $32,000 | -22.0% | 8,224 | -19.7% | 0.00% | – |
| Q2 2019 | $41,000 | +78.3% | 10,240 | +212.5% | 0.00% | – |
| Q1 2019 | $23,000 | -53.1% | 3,277 | -29.2% | 0.00% | – |
| Q3 2018 | $49,000 | +345.5% | 4,629 | +444.6% | 0.00% | – |
| Q2 2018 | $11,000 | -15.4% | 850 | -24.2% | 0.00% | – |
| Q1 2018 | $13,000 | +44.4% | 1,122 | +31.4% | 0.00% | – |
| Q4 2017 | $9,000 | – | 854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $15,889,000 | 50.04% |
| TRV GP II, LLC | 2,790,964 | $19,593,000 | 12.78% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $23,379,000 | 5.63% |
| Partner Investment Management, L.P. | 296,961 | $2,085,000 | 2.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 431,193 | $3,027,000 | 0.28% |
| PFM Health Sciences, LP | 1,463,208 | $10,272,000 | 0.23% |
| Perceptive Advisors | 132,300 | $929,000 | 0.03% |
| Fosun International Ltd | 29,877 | $209,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,200 | $584,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 343,574 | $2,412,000 | 0.01% |